A. baumannii is known as the most frequently isolated organism in intensive care units (ICUs), causing a variety of nosocomial infections, including pneumonia, urinary tract infections (UTIs), bacteremia as well as skin and soft tissue infections. These infections are usually associated with high mortality rates ranging between 26% among hospitalized patients and 43% among ICU patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
A. baumannii antibiotic susceptibility profile
Timeframe: October 2024 to December 2025
Isolation and identification of A. baumannii from different clinical samples
Timeframe: October 2024 to December 2025
A. baumannii strains which produce biofilm
Timeframe: October 2024 to December 2025
Ability of ZnO NPs to inhibit the phenomenon of biofilm formation by MDR A. baumannii strains
Timeframe: October 2024 to December 2025
The effect of ZnO NPs on the expression of some efflux pump genes and biofilm related genes in MDR A. baumannii strains
Timeframe: October 2024 to December 2025
Shimaa Anwar Ahmed, Assistant Lecturer